The pharmacologic treatment of short bowel syndrome: new tricks and novel agents

Matthew L. Bechtold, Stephen A. McClave, Lena B. Palmer, Douglas L. Nguyen, Lindsay M. Urben, Robert G. Martindale, Ryan T. Hurt

Research output: Contribution to journalReview article

11 Scopus citations

Abstract

Short bowel syndrome (SBS) is a manifestation of massive resection of the intestines resulting in severe fluid, electrolyte, and vitamin/mineral deficiencies. Diet and parenteral nutrition play a large role in the management of SBS; however, pharmacologic options are becoming more readily available. These pharmacologic agents focus on reducing secretions and stimulating intestinal adaptation. The choice of medication is highly dependent on the patient's symptoms, remaining anatomy, and risk versus benefit profile for each agent. This article focuses on common and novel pharmacologic medications used in SBS, including expert advice on their indications and use.

Original languageEnglish (US)
Article number392
JournalCurrent gastroenterology reports
Volume16
Issue number7
DOIs
StatePublished - Jan 1 2014

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'The pharmacologic treatment of short bowel syndrome: new tricks and novel agents'. Together they form a unique fingerprint.

  • Cite this

    Bechtold, M. L., McClave, S. A., Palmer, L. B., Nguyen, D. L., Urben, L. M., Martindale, R. G., & Hurt, R. T. (2014). The pharmacologic treatment of short bowel syndrome: new tricks and novel agents. Current gastroenterology reports, 16(7), [392]. https://doi.org/10.1007/s11894-014-0392-2